Genome Web Breaking News
- Co-Diagnostics Closes $5M Offering of Shares
- Saga, Servier Sign Liquid Biopsy Services Deal
- Predictive Technology Group, Atrin Pharmaceuticals Launch Oncology MDx Collaboration
- PerkinElmer Q4 Revenues Rise 7 Percent
- CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients
Stat
- STAT Plus: The FDA wants to know how Instagram influencers sway patient views on medicines
- STAT Plus: With new rules, FDA aims to spark competition, lower prices for expensive gene therapies
- STAT Plus: Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?
- Drug makers face more securities-fraud lawsuits, and so do cannabis companies
- Top Harvard chemist charged with lying about ties to Chinese government program
NYT science news
Xconomy news
- Third Time’s the Charm as Acceleron Drug Shows Early Promise in PAH
- BioIntelliSense Debuts ”Sticker” Sensor to Capture Patient Data Remotely
- Passage Bio Appoints Deerfield Management’s Bruce Goldsmith as CEO
- Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report
- Flagship Adds Fertility-Focused Ohana Biosciences to Biotech Family
Fierce Biotech
- Philips to drop its home appliances unit in healthcare pursuit, with a new head of connected care
- Life after Novartis: Jimenez joins board of Bayer-backed cell therapy startup
- Pfizer cans early-stage trials for cancer, sickle cell targets
- Adrangi mounts short attack on 'worthless' drugs of Sanofi ally
- Sorrento rejects $1B buyout bid from unnamed private equity firm
Fierce Medical Devices
- Philips to drop its home appliances unit in healthcare pursuit, with a new head of connected care
- Tracking not just data, but individual symptoms: BioIntelliSense exits stealth with FDA-cleared wearable
- GT Medical secures expanded GammaTile clearance in newly diagnosed brain tumors
- Flagship's Ohana Biosciences debuts with sperm-focused fertility platform
- Verily nets irregular pulse clearance for its clinical study smartwatch